Comment by rayiner

To play devil's advocate: what incentive does a private company have to do all the lab work necessary to identify a particular gene sequence as being predictive of cancer and make it publicly known? Without patents, Myriad would've just kept the gene sequence in question secret instead of publishing it. Would someone have rediscovered the proper sequence before Myriad's patent term would've expired? What would be their incentive to share it?